Related coverage linked through entity extraction aliases.
Aug 12, 2026
Perspective Therapeutics plans May 2026 analyst event, Q1 results, and conference appearances. The radiopharmaceutical firm is advancing 212Pb-based therapies in Phase 1/2a trials and expanding facilities.
Feb 25, 2026
Medtronic's diabetes unit MiniMed is seeking up to $7.86 billion valuation in its U.S. IPO while cutting 81 jobs at its Northridge facility ahead of the planned separation into a standalone publicly traded company.
Feb 16, 2026
Worldwide Clinical Trials has completed its acquisition of Catalyst Clinical Research, expanding its oncology capabilities and functional service provider model. The combined organization employs approximately 4,400 professionals across more than 70 countries.
Feb 13, 2026
Global pharmaceutical companies are accelerating licensing deals for China-developed experimental medicines, with deal values reaching unprecedented levels in 2026 as firms cut costs ahead of patent expirations.
